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Abstract
Introduction: Cancer is a leading cause of illness globally, yet our understanding of the financial implications of
cancer caused by working conditions and environments is limited. The goal of this study is to estimate the costs of
productivity losses due to occupational cancer in Canada, and to evaluate the factors associated with these costs.
Methods: Two sources of data are used: (i) Individual level administrative claims data from the Workers
Compensation Board of Nova Scotia; and (ii) provincial aggregated cancer claims statistics from the Association of
Workers Compensation Boards of Canada. Benefits paid to claimants are based on actuarial estimates of wage-loss,
but do not include medical costs that are covered by the Canadian publicly funded healthcare system. Regional
claims level data are used to estimate the total and average (per claim) cost of occupational cancer to the
insurance system, and to assess which characteristics of the claim/claimant influence costs. Cost estimates from one
region are weighted using regional multipliers to adjust for system differences between regions, and extrapolated
to estimate national costs of occupational cancer.
Results/Discussion: We estimate that the total cost of occupational cancer to the Workers’ Compensation system
in Canada between 1996 and 2013 was $1.2 billion. The average annual cost was $68 million. The cancer being
identified as asbestos related were significantly positively associated with costs, whereas the age of the claimant
was significantly negatively associated with costs. The industry type/region, injury type or part of body affected by
cancer were not significant cost determinants.
Conclusion: Given the severity of the cancer burden, it is important to understand the financial implications of the
disease on workers. Our study shows that productivity losses associated with cancer in the workplace are not
negligible, particularly for workers exposed to asbestos.
Background
The incidence of cancer in Canada was higher than the
global average in 2012; more than 290 individuals per
100,000 population were diagnosed with cancer, as com-
pared to a global average of approximately 190 per 100,000
[1] This can create an emotional and financial burden on
patients and their families, the latter in the form of health
care costs, and also costs of missed employment.
Health care costs to individuals are defrayed in Canada
by virtue of the health care system being predominantly
publicly funded from general taxation revenues. While
drugs are typically not included on the public reimburse-
ment list, many cancer drugs are funded publically [2].
Costs of lost earnings can also be partially defrayed for
workers whose cancer diagnosis can be attributed to
their working conditions or environment. In those cases,
workers can lay claims against their employer.
The Workers’ Compensation system in Canada is an in-
surance system that protects employers against the risk of
work-related injury claims. It was established in the early
parts of the 20th century. The general premise behind the
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program is that workers relinquish their right to sue em-
ployers in the event of workplace injury, but gain compen-
sation benefits in exchange [3]. Each injury/fatality claim
is carefully reviewed to establish attribution of the injury
or illness to workplace conditions. The Workers’
Compensation system in Canada has been characterized
as parallel to the publicly funded provincial insurance [3].
When workers in Canada develop cancer that is attrib-
utable to the conditions or environments of their work-
place, typically referred to as occupational cancer [4], they
may file a claim with the Workers’ Compensation Board
(WCB). Even though several types of industry have been
identified as posing a higher risk of cancer for their
workers (construction, fire-fighting, mining, etc.) [5], the
specific causes of any individual’s cancer can be challen-
ging to identify, however. Multiple factors can contribute
to the illness, and there is often latency between cause and
diagnosis [6, 7]. Claims may therefore be rejected.
Canada has 12 WCBs, individually representing each of
the provinces and territories, with the exception of
Northwest Territories and Nunavut, which share a program.
Table 1 outlines the characteristics of these provincial
boards. The Workers’ Compensation system has been de-
veloping and evolving over the majority of the previous cen-
tury. Not unlike other national systems in Canada, it has
evolved at different speeds and in different directions in the
various jurisdictions. The status quo is such that the features
of the WCB vary across provinces in the amounts that a
worker can expect to receive in compensation, the percent-
age of regular earnings recovered, and the requirements
placed on employers in the case of a workplace injury.
The amounts of benefits paid to workers by a
Workers’ Compensation Board are based on an actuarial
estimation of earnings losses that occur as a result of the
injury or illness. As such, the amount of benefits can
serve as a proxy to understanding the amount of wage
loss, which in turn signals productivity loss resulting
from a specific injury or illness.
Literature
Occupational cancer is the leading cause of work-related
death in Canada and rates of accepted claims have generally
increased since 1997 in Canada [8, 9] and the United
Kingdom [10]. Moreover, asbestos-related cancer accoun-
ted for nearly 70% of all compensated deaths and most
typically affect those with manual labour professions
[8, 11]. While the incidence of these reports are clear,
measuring the cost of occupational cancer remains difficult.
Little is known about the costs of occupational cancer
to a health care system, or any of its components. Esti-
mates in the literature rely on administrative records,
national aggregate statistics, and/or questionnaires to
estimate occupational cancer costs. All rely on assump-
tions made about the transferability of incomplete or im-
perfect data to estimate the incidence and/or prevalence
of occupational cancer and/or its cost. For this reason,
there is a limited number of published studies that esti-
mate the burden and/or costs of occupational cancer
(Additional file 1: Appendix A1).
The creativity of some approaches published in the lit-
erature signals the difficulty of finding reliable data re-
garding the costs of occupational cancer. For example,
Fritschi and Driscoll [12] use Finnish estimates of the
proportion of cancers caused by occupation to estimate
occupational cancer rates in Australia. They use EU esti-
mates of the proportion of workers exposed to carcinogens
and apply to Australian industry profiles [12]. Other stud-
ies of occupational cancer do not contain cost estimates.
Table 1 Characteristics of Workers’ Compensation Boards in Canada




Alberta Workers’ Compensation Board of Alberta 1918 $95,300 90% net
British Columbia WorkSafeBC 1917 $78,600 90% net
Manitoba Workers’ Compensation Board of Manitoba 1917 $121,000 90% net
New Brunswick WorkSafeNB 1919 $60,900 85% loss of earnings
Newfoundland and Labrador Workplace Health, Safety and Compensation Commission 1951 $61,615 90% net
Northwest Territories/Nunavut Workers’ Safety & Compensation Commission 1977 $86,000 90% net
Nova Scotia Workers’ Compensation Board of Nova Scotia 1915 $56,800 75% net (26 weeks)
then 85% net
Ontario Workplace Safety and Insurance Board 1915 $85,200 85% net
Prince Edward Island Workers’ Compensation Board of Prince Edward Island 1949 $52,100 80% net (38 weeks)
then 85% net
Quebec Commission de la santé et de la sécurité du travail 1931 $70,000 90% net
Saskatchewan Workers Compensation Board of Saskatchewan 1929 $65,130 90% net
Yukon Yukon Workers’ Compensation Health & Safety Board 1973 $77,610 75% gross
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Despite limited academic study, especially in Canada, some
conclusions can be drawn regarding the nature of occupa-
tional cancer and its labour impact, and provide the basis
for exploring new methods to estimate costs.
Internationally, the impact of occupational cancer is sig-
nificant when measured in terms of mortality. Two studies
use national mortality data to estimate the number of po-
tential or expected years of life and/or working life lost
due to occupational cancer. Binazzi et al. (2013) estimate
that on aggregate 170,000 potential years of life and
16,000 potential years of working life were lost due to oc-
cupational cancer in Italy in 2006 [13]. Lee et al. (2012) es-
timate that in Taiwan, between 1997 and 2005, the
expected years of life lost per individual were between 5
and 18 on average, depending on the type of cancer [14].
The financial cost of occupational cancer to health sys-
tems internationally is also extensive. Estimations of the
monetized costs of cancer vary across regions, years, and
the specific types of costs included in the calculation.
For example, work attributable cancers are estimated to
have cost the Spanish Basque health system close to €10
million in 2008 [15]. Costs for all of France in 2010 are
estimated between €917 million and €2.18 billion, in-
cluding direct and indirect social costs [16]. In contrast,
O’Neill estimates the cost of work-related cancers in the
UK to be in the order of £30 to £60 billion per year,
which is a much higher estimate [17].
The cost of occupational cancer in Canada is comparable
to international estimates, but the Canadian literature em-
ploys a multitude of measurement strategies, particularly at
the provincial levels. For example, Hopkins et al. [18] use
data from the Canadian Community Health Survey, as well
as published numbers from the literature to estimate the
national-level cost of occupational cancer in terms of wage
loss in 2009. They estimate that workers (patients) and their
families have lost $ 3.18 billion [18]. Orenstein et al. [19] es-
timate that the indirect costs (loss of economic resources
and reduced productivity) in Alberta alone are approxi-
mately $64 million per year, and that the province incurs
approximately $16 million per year in medical system costs.
While Quebec estimates that occupational diseases account
for approximately $834 million dollars annually in worker’s
compensation claims and occupational disease related
deaths cost approximately $128 million, exact figures re-
garding the cost of occupational cancer were unclear [11].
Additionally, the number of compensated occupational
cancer claims has also grown progressively in Ontario,
however the true burden of occupational cancer is yet to be
properly estimated [8]. Due to the lack of literature focusing
on all Canadian provinces, particularly Nova Scotia, under-
standing the cost of occupational cancer is relatively un-
known. Estimating and exploring the determinants of the
cost of occupational cancer claims in Nova Scotia, as well
as nationally by province must be attempted.
Methods
The goal of this study is twofold: (i) to understand the
structure of occupational cancer costs borne by the
WCB in Nova Scotia, and (ii) to estimate the national
burden of occupational cancer using the NS data.
Two models are developed, a regional model and a na-
tional model. The regional model estimates the total
costs and average costs per cancer related claim, and the
determinants of costs at the level of the province (Nova
Scotia). The national model extrapolates national level
costs from the regional level using NS average cost per
claim, the number of claims per province/territory per
year, and a weighing technique to account for differences
in the provincial/territorial WCB systems.
Data
We use two sources of data: (i) the Nova Scotia
Workers’ Compensation Board (WCB) administrative
claims records, and (ii) the Association of Workers’
Compensation Boards of Canada (AWCBC) aggregated
statistics available online or through customized order.
The Nova Scotia WCB records were made available at
the individual claims level from 1957 to 2015 and includes
all claims with and without time-loss. The records include
the short and long term earnings loss benefits paid to indi-
viduals up until September 22nd, 2015. Other variables
available were age in years at the time of the biopsy (<50,
51–64, 65+), industry that the incident occurred (govern-
ment, construction, manufacturing, and other), type of can-
cer (occupational, asbestos, fire fighter, and missing), type
of injury (Asbestosis, Leukemias, Lymphosarcoma and
Reticulosarcoma, neoplasms and tumors, Mesothelioma,
other, and unknown), region injury occurred (Halifax-East
Shore-West Hants, Annapolis Valley-South Shore-South
West, Colchester-East Hants-Cumberland-Pictou, Cape
Breton-Guysborough-Antigonish, other, and missing), and
type of body part affected (abdomen/digestive, urinary sys-
tems, body systems, respiratory system, circulatory system,
head and neck, pelvic region, other, and missing). The
categorization within variables was exploratory and largely
dictated by the nature of the WCB records. Where appro-
priate categories within variables were collapsed. There
were 385 occupational related cancer claims accepted by
the Nova Scotia WCB. Claims were dropped from analysis
if there was no cost accrued or reported by the WCB
(21.0%). Overall, 304 claims with 298 men and six women
were included in this study.
For the national model, we used two data-sets from
the AWCBC:
1. The total annual costs of all claims and the number
of time-loss claims per province/territory for the
years 1996 to 2013 was obtained through the online
request (http://awcbc.org/?page_id=14). Cost per
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claim per province per year was calculated
(not cancer specific).
2. The number of time-loss claims per province/
territory per year for the years 1996 to 2013 for each
injury/fatality type, including cancer was obtained
through customized order. The full list of cancer
types included is in Additional file 1: Appendix A2.




Total cancer cost in Nova Scotia (TCNS) included indi-
vidual short term disability benefits, long term disability
benefits, and medical costs. The total cost per claim was




TCpcNS;t  πt ð1Þ
Where TCNS is the total cost in Nova Scotia, TC
pc
NS;t is
the total cost per claim in Nova Scotia in year t, and πt
is inflation in year t.
To account for inflation, we used the Consumer Price
Index (CPI) base year 2014 data from Statistics Canada
[20]. Assumptions about the region and composition of
the CPI were required. Furthermore, assumptions about
the year(s) of payout for each claimant were required, as
this was missing from the data. As a result, we provide
eight estimates of TCNS (Table 2) for comparison of the
implications of assumptions.
First, the CPI is available at the national level, and
since 1979 it is also at the provincial/territorial levels.
Cost calculations using provincial CPI values are there-
fore challenging for years prior to 1979, and the national
CPI is used in those years. This is compared to cost cal-
culations using the national CPI for all years 1957 to
2015. Second, the CPI is available for all goods and ser-
vices, and it is also available specifically for goods and
services related specifically to health and personal care.
Estimates using both are compared. Third, for purposes
of inflation adjustment, assumptions had to be made
about the year in which benefits were paid to claimants.
Dates of payments were not available from WCB, and
dates when claims were closed were deemed unreliable,
because claims were often re-opened. We assumed that
short term disability benefits were paid in full in the year
the claim was filed and inflation adjustment was done in
that year. Long term disability benefits are paid out over
a number of years after the claim is filed, however. Two
different years of payout were assumed for purposes of
inflation adjustment: the first year the claim was filed,
and the median year between the first and last years that
the claim was open.
Regional model – determinants of total costs per
cancer-related claim
The determinants of total costs per claim were assessed
by estimating the associations between total costs and
claim characteristics. Total cost TCpcNS
 
did not have a
normal distribution and required a natural log trans-
formation to satisfy assumptions necessary to perform
linear regression. Univariate analyses, full-model mul-
tiple linear regression, and a parsimonious- multiple re-
gression model on natural log transformed total cost
were conducted. Equation [2] shows the approach used
to estimate the drivers of inflation adjusted total cost per
cancer claim.
Ln TCpcNS
  ¼ αþ X 0βþ ε ð2Þ
Where α is the intercept, X’ are the claims characteris-
tics (injury type, cancer type, body part affected, age of
claimant at biopsy, industry type, region), β is a vector of
estimated coefficients, and ε is the error term.
National model
The WCB benefits costs related to occupational cancer
in Canada were estimated in a series of three steps: (1)
regional model estimation of average cost per claim (NS
WCB data); (2) estimation of provincial multipliers to
capture the relative differences between Provinces
(AWCBC data); and (3) estimation of annual and total
costs of occupational cancer in Canada by province/
territory (NS WCB and AWCBC data).
The average cost per claim in Nova Scotia was calcu-
lated using the estimates from the regional model. Equa-
tion [1] shows the approach used to estimate the average
cost (AC) per claim in Nova Scotia.
Table 2 Combinations of assumptions used for inflation adjustment of costs
CPI – national level CPI – national level
CPI – all items CPI – health and personal care CPI – all items CPI – Health and personal care
Year (First Year of Claim) Cost Estimate 1 Cost Estimate 2 Cost Estimate 5 Cost Estimate 6
Year (Median Year of Claim) Cost Estimate 3 Cost Estimate 4 Cost Estimate 7 Cost Estimate 8





Where ACpcNS is the average cost per claim, TCNS is the
total cost per claim, and nNS is the number of claims in
Nova Scotia. The confidence interval for the ACpcNS is
found as follows:




Provincial multipliers introduced here are weighted in-
dices developed to account for general differences in the
WSB systems across provinces, specifically for the sys-
temic relative differences in the costs of claims. Systemic
relative differences refer to those outlined in Table 1,
namely differences in the maximum compensated earn-
ings, and the percentages of earnings considered as a
basis for benefits. The multipliers are calculated using
the average cost per claim in each province for all types
of claims, not restricted to cancer, including short term
and long term benefit costs, but not administrative costs
(using AWCBC data).1 For each province, we calculate
an annual average cost per claim AACitpc , where i is the
province and t is the year. The multiplier reflects the
relative size of the average cost per claim in province i





The multiplier is calculated as per equation [5], where






The approach that was used to estimate the average
cost of time-loss claims related to occupational cancer
from the perspective of the WCB per claim per province
is shown in equations [6] and [7]. We assume that all
claims in Canada are independent and identically distrib-
uted, and follow the same distribution as claims in Nova
Scotia, with the same mean and standard deviation. To
derive mean and standard deviation for province i, we
adjust for the mean provincial multiplier.
ACi ¼ Mit  ACNS ð6Þ
σ i ¼ Mit  σNS ð7Þ
This is the average cost per claim in Nova Scotia dis-
counted by the provincial multiplier. The average cost
per claim, standard deviation, and 95% confidence inter-
vals for Canada as a whole are found as per equations
[8], [9] and [10].
Table 3 Characteristics of Nova Scotia Workers’ Compensation




















Lymphosarcoma and Reticulosarcoma 2.30





Halifax, East shore, West Hants 17.43
Annapolis Valley, South Shore, South West 1.97
Colchester-East Hants, Cumberland, Pictou 3.62


































This approach to the calculation of national level costs
is unique and to the best of our knowledge, has not been
used in the literature.
Results
Regional model
Descriptive statistics are reported for the full set of Nova
Scotia WCB administrative claims related to occupa-
tional cancer. Table 3 shows the characteristics of the
304 records from 1957 to 2015. The majority of claims
(88.16%) were made at a biopsy age of over 50 years, ap-
proximately half (50.99%) were from the manufacturing
sector, and claims typically came from the Nova Scotia
regions of Cape Breton, Guysborough, and Antigonish.
Government workers (32.24%) made a higher percentage
of claims than workers in construction (6.25%) and other
industries (10.53%). The public sector in Nova Scotia
employs many occupations, including construction,
therefore the distinction may be blurred. The most com-
mon type of occupational cancer is unspecified (49.01%),
most often affects the respiratory system (55.92%) and
the cancer usually manifests as neoplasms and tumours
(50.66%). Asbestos exposure was the most common
(26.97%) form of unspecified cancer claim.
Estimates of the total costs (TCNS) and average cost
per claim ACpcNS
 
of occupational cancer in Nova Scotia
are presented in Table 4. Eight estimates are presented
according to the assumptions made about inflation, as
discussed above (figure 1). The range of total cost
estimates was between $36.5 million (CPI regional,
health and personal care, last year) and $44.0 million
(CPI regional, all items, median year). The range of aver-
age cost per claim was between $120,182 and $145,807.
Assumptions about the CPI influenced the estimates,
but differences in estimates were not statistically signifi-
cant. It is important to note that the cost estimates may
change over time, because several claims are still open
and continue to accrue costs.
The analysis of the determinants of the cost per claim in
Nova Scotia presented here focuses on cost estimate 8,
based on the regional health related CPI and using the mid-
point year. Results do not appear to be sensitive to the
choice of cost estimate (Additional file 1: Appendix A3). Re-
sults of unadjusted (univariate) and adjusted (multivariate)
linear regression models of natural log transformed cost
estimates are provided in Table 5 for both a full and a par-
simonious model. The full-model included, age in years at
the time of the biopsy, industry that the incident occurred,
type of cancer, type of injury, region, and type of body part
affected. The parsimonious model includes age at the time
of the biopsy, industry that the incident occurred, and
cancer type. All models indicate p-values including,
p < 0.01, p < 0.05, and p < 0.1. All beta-coefficients are
exponentiated and expressed as a percentage of the effect
on total cost compared to the referent.
Overall, our results suggest that the average costs per
WCB cancer claim are influenced by the age of the
claimant and the cancer type being related to asbestos.
Specifically, results show that the costs of claims of in-
dividuals who were 65 years and older at time of biopsy
were significantly lower compared to individuals 50 years
or younger. Cost were lower by approximately 67% in
the unadjusted model (p < 0.1), and 82% in the adjusted
full model (p < 0.01) and 80% in the parsimonious model
(p < 0.01). Furthermore, claims for asbestos related can-
cer were substantively more costly than the general un-
specified occupational cancer type. Costs were higher by
363% in the unadjusted model (p < 0.01), 1309% higher
Table 4 Nova Scotia - total cost of all cancer claims and the average cost of cancer claims (95% confidence intervals, adjusted for
inflation using combinations of three assumptions: CPI region; CPI composition; year of claim)
Cost estimate CPI assumptions (2014 base year) Total cost ($ ‘000) Average cost ($ ‘000) 95% CI ($ ‘000)
1 National Last Year All Items 37 500 123 107 – 140
2 Healthb 36 800 121 105 – 137
3 Median Year All Items 43 100 142 122 – 162
4 Healthb 41 400 136 117 - 155
5 Regionala Last Year All Items 37 900 125 108 – 141
6 Healthb 36 500 120 104 – 136
7 Median Year All Items 44 000 145 124 – 165
8 Healthb 40 500 133 115 – 152
aCombination of the National CPI until 1979 and the Nova Scotia CPI in 1979 and thereafter
bHealth and Personal Care Items
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Table 5 Determinants of occupational cancer costs in Nova Scotia – cost estimate 8
Unadjusted Adjusted full model Adjusted parsimonious model
Age at biopsy
<=50 1 1 1
51–64 4.13% −21.69% −21.11%
65+ −67.08%* −81.83%*** −79.81%***
Industry
Government 1 1 1
Construction 173.74% 173.22% 163.21%
Manufacturing −0.32% 6.30% 55.19%
Other −71.96%* −61.38% −64.75%
Cancer type
Occupational 1 1 1
Asbestos 362.61%*** 1308.63%*** 555.68%***
Fire Fighter 94.57% 165.25% 140.73%




Lymphosarcoma and Reticulosarcoma −30.25% 96.03%





Halifax, East shore, West Hants 1 1
Annapolis Valley, South Shore, South West 114.26% 26.59%
Colchester-East Hants, Cumberland, Pictou −59.90% −2.97%





Urinary System 126.23% 126.42%
Body Systems 185.17% 26.36%
Respiratory System 8.94% 2.99%
Circulatory System −31.00% −52.84%
Head and Neck −73.36% −74.76%
Pelvic Region −37.69% −3.41%
Other −38.65% −69.28%
Missing −63.66% −81.03%
Unadjusted and adjusted linear regression models were log transformed. Values shown are exponentiated to estimate the geometric mean, expressed as a percentage
of change in total cost compared to the referent
Estimates are adjusted for the national (1957–1978) and Nova Scotia (1979–2015) Consumer Price Index for Health and Personal Care
Inflation was determined using year of biopsy
***p < 0.01, **p < 0.05, *P < 0.1
N = 304
Total cost: $40 500 000
The bold-face entries are highlighting those results that are statistically significant
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in the full adjusted model (p < 0.01), and 556% higher in
the adjusted parsimonious model (p < 0.01) relative to un-
specified occupational cancer claims. Costs were also in-
fluenced by injury type and region within Nova Scotia
being reported as ‘other’. The effects of industry type were
statistically significant only in the unadjusted model, but
became insignificant after adjustment for covariates. Cost
did not depend on the body part affected. Cost per claim
by gender was not examined because there were too few
women in the sample (fewer than 10).
National model
Results of the estimation of Provincial multipliers are re-
ported in Table 6. Multipliers show the interprovincial
variation in the costs of benefits paid by Provincial
WCBs across all claims, including but not limited to
cancer. A multiplier lower than one indicates that the
Province’s WCB typically has lower benefits when com-
pared to Nova Scotia, for example Alberta, British
Columbia, Quebec, and Manitoba. A multiplier higher
than one indicates that the Province’s WCB typically has
higher benefits when compared to Nova Scotia, for ex-
ample Ontario and New Brunswick.
The burden of occupational cancer is captured in
Table 7 showing the number of claims made in each
Province between 1996 and 2013, as well as Canada
wide. Nunavut/NWT, New Brunswick and Prince
Edward Island had the lowest number of claims, and
Ontario, Quebec and British Columbia had the highest
number of claims.
The estimated costs of work-related cancer to the
WCB system in Canada and by province are shown in
Table 8. The average cost of per claim in Nova Scotia is
estimated on the basis of the claims-level Nova Scotia
data. The average costs per claim for other provinces are
estimated using the multiplier approach (based on
AWCBC data). Table 8 also reports on the total cost of
occupational cancer between 1996 and 2003 for each
province, as well as for Canada as a whole. The total cost
in Canada between 1996 and 2003 was approximately
$1.2 billion, and the average cost per year was approxi-
mately $68 million.
Discussion
Our study explores the determinant of cost of cancer
claims in Nova Scotia and provides insight into an area
little investigated. Our estimates from the parsimonious
model suggest that claims with asbestos related cancer
have a fivefold increase in cost compared to unspecified
occupational cancer claims. Del Bainco and Demers [8]
observed that in Ontario, the number of accepted claims
for occupational cancer-related deaths have increased
between 1997 and 2010, and that it was most often as a
result of exposure to asbestos, commonly experienced in
high risk industries. Our results complement their find-
ings, suggesting that while asbestos related cancers are
becoming more commonly reported, they are also sig-
nificantly more costly than other occupational cancer
claims. This association is independent of the type of
industry in which the claimant acquired the illness.
Further investigations into the mechanisms by which as-
bestos exposure claim increase costs are needed.
We also find that older claimants accrue significantly
(80%) lower costs than younger claimants. We have not
found comparable findings in the literature. Given that
long term benefits primarily reflect lost wages, the likely
explanation is that many claimants over the age of 65 do
not qualify for wage replacement benefits due to
retirement.
Our estimates are conservative estimates of the costs
of occupational cancer in Canada as faced by the WCB
Table 6 Provincial WCB multipliers
Province Multiplier in 2013 Average multiplier
(1996–2013)
Alberta 0.69 0.87
British Columbia 0.78 0.78
Manitoba 0.41 0.39
New Brunswick 0.99 1.22
Newfoundland 0.90 1.09
Nova Scotia 1.00 1.00
Nunavut/NWT 0.87 1.24
Ontario 1.03 1.50




Table 7 Time-loss claims by province
Province Number of new claims Claims in 2013a
Alberta 758 83
British Columbia 1242 92
Manitoba 127 12
New Brunswick 17 5
Newfoundland 115 18
Nova Scotia 57 6
Nunavut/NWT 4 -
Ontario 3540 150




Total for Canada 8261 541
aProvincial reporting is not complete for 2013, some values are missing
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system. Our results likely underestimate the true costs,
because the data available through the AWCBC is not
complete, given that it relies on provincial reporting. It
is also a conservative estimate, since all claims approved
by WCB have been reviewed and determined to be can-
cers attributed to work conditions. More cases of occu-
pational cancer may exist, but remain unclaimed, or
claims are rejected due to insufficient evidence. Discrep-
ancies between the average 1996–2013 costs and the
total costs are present, because data are not reported for
all years for all provinces. Estimations are based only on
reported data. For example, the average cost per year in
Manitoba is based on 15 years of data, not 18.
Our estimates of the cancer burden, in terms of num-
ber of claims accepted, are relatively lower than those re-
ported in the literature. There are three reasons. First,
the AWCBC reports only time-loss claims, and does not
include claims of individuals who continue to work
while ill. This difference could be substantial. For ex-
ample, the Nova Scotia dataset records 248 new claims
between 1996 and 2013, whereas the AWCBC database
records 57 time-loss claims in that same time period, i.e.
only 23% of all claims were time-loss claims. Second, the
number of claims filed and claims approved by the in-
surance is naturally lower than the number of cases of
occupational cancer, since some patients do not file a
claim, and some claims are not approved.
Since 1996, the Canadian WCB system has paid ap-
proximately $ 1.2 billion for work related cancer claims,
at an average annual cost of approximately $66 million.
Ontario faced the highest cost in total and on average,
followed by Quebec, British Columbia and Alberta. This
is not surprising, given that Ontario has the highest
number of approved claims, and pays the highest bene-
fits relative to other provinces. Quebec pays relatively
lower benefits, but faces a higher number of approved
claims compared to Ontario.
The cost to the WCB insurer does not account for the
costs to the health care system that were incurred
outside of the WCB claim. Many claimants living with
cancer bring their claim to the WCB after the illness has
progressed and treatment has begun or has been com-
pleted. The WCB does not reimburse the public health
system for the costs of care retroactively.
The cost to the WCB insurer serves as a meaningful
proxy to the estimation of wage loss due to occupational
cancer for workers. It does not account for wage loss
due to cancer that is not work-related, nor does it ac-
count for the wage loss of family members affected. Fur-
thermore, the payments made by the WCB have upper
limits based on the maximum insurable earnings thresh-
old and insure less than 100% of earnings (Table 1).
Therefore, our national level estimate of $1.2 billion is
lower than the $3 billion estimated by Hopkins et al.
[18]. Similarly, our estimate for Alberta is $4.9 million,
which is lower than the $64 million estimated by Oren-
stein et al. [19]. This is consistent with our discussion,
since the other studies define productivity and wage loss
to include the loss experienced by workers afflicted with
cancer directly, and also indirectly through the loss ex-
perienced by others in the system, e.g. caregivers. Fur-
thermore, Orenstein et al. rely on an attributable risk
approach to estimate the proportion of cancer cases in
the province that are liked to working conditions,
whereas our study focuses on the number of claims
made by workers and accepted by the insurer.
Table 8 Cost of work-related cancer by province (1996 to 2013)a
Province Total cost ($ ‘000) 95% CI of total
cost ($ ‘000)
Average cost
per year ($ ‘000)
95% CI of average cost
per year ($ ‘000)
Average cost
per case ($ ‘000)
95% CI of cost
per case ($ ‘000)
Alberta 87,839 (80,138 – 95,539) 4,879 (3,065 – 6,695) 116 (106 – 126)
British Columbia 129,037 (120,199 – 137,874) 7,169 (5,086 – 9,252) 104 (97 – 111)
Manitoba 6,597 (5,184 – 8,010) 439 (75 – 805) 52 (41 – 63)
New Brunswick 2,763 (1,022 – 4,503) 691 (−179 – 1,561) 163 (60 – 265)
Newfoundland 16,696 (12,939 – 20,454) 1,518 (385 – 2,651) 145 (113 – 178)
Nova Scotia 40,492 (38,065 – 42,929) 4,049 (3,282 – 4,817) 133 (91 – 176)
Nunavut/NWT 660 (−469 – 1,789) 661 (−469 – 1,789) 165 (−117 – 447)
Ontario 707,281 (678,589 – 735,973) 39,293 (32,531 – 46,056) 199 (192 – 208)
Prince Edward Island 919 (122 – 1,716) 919 (122 – 1,716) 92 (12 – 172)
Quebec 225,001 (213,711 – 236,289) 12,500 (9,839 – 15,161) 97 (92 – 102)
Saskatchewan 2,014 (1,054 – 2,974) 403 (−26 – 832) 72 (38 – 106)
Yukon 9,464 (6,134 – 12,793) 3,155 (1,232 – 5,077) 193 (125 – 261)
Total for Canada 1,228,763 (1,208,669 – 1,248,856) 68,265 (63,529 – 73,001) 149 (146 – 151)
aRounded to nearest 1000 Canadian dollars, including only years for which data were available. Negative confidence interval caused by small number of
observations, and high variance of specific provinces, e.g. NU. There are only 1 year data for both NU and PEI, so their total cost equal average cost per year
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The limitations of our study are twofold. First, we have
a relatively small number of the WCB individual claims
data from Nova Scotia. Claims due to occupational can-
cer as a proportion of total WCB claims are less than 1%
in most years. Second, the aggregate records available
through the AWCBC appear to be incomplete, in
particular for the Territories, Saskatchewan and Prince
Edward Island, where data is not available for most of
the years between 1996 and 2013.
Conclusion
We find that the Canadian WCB insurance system spends
approximately $68 million on occupational cancer claims
annually, and has spent approximately $1.2 billion be-
tween 1996 and 2013. The study contributes to a very lim-
ited body of literature and expands our understanding of
the size and determinants of the costs of occupational
cancer. The study is based on claims of lost wages laid
against employers through the Canadian worker’s com-
pensation insurance system, which serve as an approxima-
tion of productivity losses with high face validity.
The need for programs to prevent occupational cancer
has long been recognized in Canada [21, 22] and inter-
nationally [23]. Yet our data suggest that the number of
occupational cancer claims has not been declining over
the years, and neither have the costs of claims. Increased
funding of for programs to prevent occupational cancer
may be a best strategy to cost-savings, not to mention a
reduction in the incidence of cancer.
Endnote
1The average cost per claim for all claims is likely to
be lower than the average cost per claim for cancer
claims only. Reliance on all claims in this calculation is
likely to introduce bias. Our approach overestimates the
costs of cancer for regions with a proportion of cancer
cases higher than in Nova Scotia, and vice versa.
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